Idiopathic Bile Acid Diarrhea: Colesevelam Hydrochloride Tablet

We are studying a new tablet for patients with idiopathic bile acid diarrhea to see if it improves stool consistency compared to a placebo. The trial will also evaluate the safety and tolerability of this treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Colesevelam Hydrochloride
Colesevelam hydrochloride is a substance that helps lower LDL "bad" cholesterol levels.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Colesevelam

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Az Sint-Lucas
Gastroenterology
Assebroek, Belgium
UZ Brussel
Gastroenterology and Hepatology
Ganshoren, Belgium
UZ Leuven
Division of Gastroenterology and Hepatology
Heverlee, Belgium

Sponsor: Cosmo Technologies Limited
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.